In-hospital initiation of dapagliflozin in patients hospitalized for acute heart failure (HF) did not significantly reduce the short-term risk of worsening HF or death, based on findings from the DAPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback